Growth Disorders Terminated Phase 2 / 3 Trials for Somatotropin (DB00052)

Also known as: Growth Disorder

IndicationStatusPhase
DBCOND0028940 (Growth Disorders)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02413138Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)Treatment